Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate
Status:
Withdrawn
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the proposed study is to determine the effectiveness of methylphenidate HCl
(Concerta) in college students with ADHD. This study will consist of 110 college students
between the ages of 18 and 25 who are enrolled full-time in a local or junior college. The
study consists of an 8-week double-blind, placebo-controlled trial of placebo versus
methylphenidate HCl (Concerta®) followed by a 10-week extension of open label methylphenidate
HCl (Concerta®).